Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $2.66 Million - $4.53 Million
-13,900 Reduced 93.29%
1,000 $325,000
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $305,881 - $409,811
-1,900 Reduced 11.31%
14,900 $2.84 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $524,691 - $766,719
2,700 Added 19.15%
16,800 $3.34 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $2.59 Million - $3.51 Million
11,600 Added 464.0%
14,100 $4.02 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $438,525 - $544,800
2,500 New
2,500 $542,000
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $937,008 - $1.49 Million
4,800 New
4,800 $1.34 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.